Alzheimer’s Drug Hope vs. Reality: High Costs and Barriers

Bookmark Article



Bookmark Article


On ‘Psychology Behind the Headlines,’ hosts Patricia Wu, Jessica Reyes, and guest therapist Joann ‘JoJo’ Venant discuss how the new Alzheimer’s drug promised hope but the high costs, medical hurdles, and side effects have dashed those hopes for many.

The Price of Hope

Leqembi, the Alzheimer’s drug, costs over $26,000 annually. Many insurance plans don’t cover it, making it impossible for many patients to afford.

Medical Hurdles

Getting Leqembi isn’t easy. It involves extensive testing and monitoring for brain swelling and bleeding, deterring both doctors and patients.

Emotional Toll

The hope, then disappointment, of an Alzheimer’s drug is emotionally draining for patients and their loved ones.

Editorial Team
Editorial Team
At the heart of MHTN - America's pioneering 24/7 Mental Health TV Network - is our editorial team, a dynamic group of professionals united by a shared commitment to transforming the conversation around mental health. Our team is composed of seasoned journalists, mental health experts, researchers, and storytellers, each bringing a wealth of experience and a passion for advocacy.


Please enter your comment!
Please enter your name here

Read more


Related Articles